JANSSEN GLOBAL SERVICES LLC

Company Snapshot

Founded: 1953
Entity Type: Private
Headquarter: U.S.
Key Geographics: North America, South America, Europe Middle East and Africa, Asia-Pacific
Corporate Address: 1125 Trenton-Harbourton Road Titusville, New Jersey 08560 U.S. Tel: +1-800-526-7736 Web: www.janssen.com

Company Overview

Janssen Pharmaceuticals iwas once a leading provider of contraceptive products for women. The company offered a full line of oral contraceptives, transdermal contraceptive patches and other methods of contraception. Janssen’s contraceptive products include Ortho Evra, Ortho Micronor, Ortho-Tri-Cyclen, Ortho-Cept and others are discontinued in the market and generic version of these drugs are available.

History: Ortho-McNeil-Janssen Pharmaceuticals’ operating units were united under the Janssen name in June 2011. These companies — McNeil Pediatrics, Ortho-McNeil, Ortho Women’s Health & Urology, Ortho-McNeil Neurologics, PriCara, and Janssen (which previously focused solely on mental health) — are now an integrated group with increased capabilities to enhance resources and focus on product innovation, customer service, and organizational excellence. Janssen Pharmaceuticals is a division of the pharmaceutical giant, Johnson & Johnson.

JANSSEN GLOBAL SERVICES LLC In Reports

Type 2 Diabetes Treatment: Global Market Outlook

BCC Research Market Report for Type 2 Diabetes Treatment market. Industry growth drivers, restraints, trends, and opportunities in the type 2 diabetes treatment market are also discussed in detail.

Human Reproductive Technologies: Products and Global Markets

BCC Research Market Analysis Report Says human reproductive technologies and products is valued at $16.1 bln in 2021 and is estimated to grow from $17.1 bln in 2022 to $24 bln in 2027.

Antifungal Drugs: Technologies and Global Markets

BCC Research Market Report says market for antifungal drugs should grow from $14.5 billion in 2021 to $17.9 billion by 2026 with a CAGR of 4.4%

Company's Business Segments

  • Pharmaceutical, Biotechnology, and Medical Technologies  : This segment provides products and solutions for advanced treatments and biomedicines to treat immune-related diseases.

Applications/End User Industries

  • Neuroscience
  • Immunology
  • Oncology
  • Cardiovascular
  • Metabolism & Retina
  • Patient Engagement
  • Pulmonary Hypertension
  • Infectious Diseases & Vaccines